{
  "symbol": "CRSP",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "gene editing technology", "small-cap status"],
    "riskScore": 7,
    "reason": "CRISPR Therapeutics operates in the biotechnology sector with a focus on gene editing, which is a hype-prone area. Its small-cap status and innovative technology make it susceptible to retail-driven price movements."
  }
}